Skip to main navigation
Skip to search
Skip to main content
WashU Medicine Research Profiles Home
Help & FAQ
Link opens in a new tab
Search content at WashU Medicine Research Profiles
Home
Profiles
Departments, Divisions and Centers
Research output
Pathogens in severe sepsis: New paradigms for gram-positive treatment
Lee P. Skrupky
, Scott T. Micek
,
Marin H. Kollef
Institute of Clinical and Translational Sciences (ICTS)
Division of Pulmonary & Critical Care Medicine
Research output
:
Chapter in Book/Report/Conference proceeding
›
Chapter
›
peer-review
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Pathogens in severe sepsis: New paradigms for gram-positive treatment'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Methicillin-resistant Staphylococcus Aureus
100%
Severe Sepsis
100%
Gram-positive
100%
Positive Treatment
100%
Methicillin-resistant Staphylococcus Aureus Infection
33%
Pneumonia
16%
Patient Outcomes
16%
Virulence Factors
16%
Adverse Outcomes
16%
Critically Ill
16%
Healthcare-associated
16%
Vancomycin
16%
Empiric Antibiotics
16%
Treatment Delay
16%
Intensive Care Unit
16%
Nosocomial Pathogens
16%
Resistance Factor
16%
Resistance Epidemiology
16%
Resistance Pattern
16%
Hospital Care
16%
Most Common Cause
16%
Bacteremia
16%
Gram-positive Bacteria
16%
Gram-positive Pathogens
16%
Skin Structure
16%
Pharmacology, Toxicology and Pharmaceutical Science
Sepsis
100%
Infectious Agent
100%
Methicillin-Resistant Staphylococcus Aureus
100%
Infection
33%
Methicillin Resistant Staphylococcus Aureus Infection
33%
Adverse Outcome
16%
Antibiotics
16%
Virulence Factor
16%
Bloodstream Infection
16%
Gram Positive Bacterium
16%
Vancomycin
16%
R-Factor
16%
Nursing and Health Professions
Sepsis
100%
Methicillin-Resistant Staphylococcus Aureus
100%
Infection
33%
Methicillin Resistant Staphylococcus Aureus Infection
33%
Intensive Care Unit
16%
Vancomycin
16%
Treatment Outcome
16%
Bloodstream Infection
16%
Hospital Care
16%
Adverse Outcome
16%
Virulence Factor
16%
R Factor
16%